Crisaborole memba ne na ajin benzoxaboroles wanda shine 5-hydroxy-1,3-dihydro-2,1-benzoxaborole wanda a ciki yana da phenolic.hydrogenAn maye gurbinsu da ƙungiyar 4-cyanophenyl. A phosphodiesterase 4 inhibitor da ake amfani da shi don maganin m zuwa matsakaici atopic dermatitis a cikin yara da manya. Yana da matsayi a matsayin mai hana phosphodiesterase IV, anantipsoriaticda kuma maganin da ba steroidal anti-inflammatory. Yana da benzoxaborole, ether mai ƙanshi da nitrile.

Crisaborole labari neoxaboroleFDA ta amince da shi a ranar 14 ga Disamba, 2016 a matsayin Eucrisa, magani na Topical don m zuwa matsakaici atopic dermatitis. Wannan wakili ba na steroidal yana da tasiri a inganta yanayin cututtuka, rage haɗarin kamuwa da cuta da rage alamun da alamun bayyanar cututtuka a cikin marasa lafiya 2 shekaru da haihuwa. Yana rage ƙumburi na gida a cikin fata kuma yana hana ƙarin cutar da cutar tare da kyakkyawan bayanin martaba. Tsarinsa ya ƙunshi aboronatom, wanda ke sauƙaƙe shigar fata da ɗaure zuwa cibiyar bimetal na phosphodiesterase 4 enzyme. A halin yanzu ana ci gaba da haɓakawa azaman jiyya na maganin psoriasis.

Crisaborole shine mai hanawa phosphodiesterase 4. Tsarin aikin crisaborole shine azaman Mai hanawa na Phosphodiesterase 4.